CClinicalTrials.gg
CompletedNCT01975402R01-Aim2Updated May 21, 2019

Evaluation of the BodyGuardian End-to-end Remote Monitoring Platform in an Outpatient Heart Failure Population

An observational study in Congestive Heart Failure, sponsored by Mayo Clinic. Completed at 3 sites in United States. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2019-05-21.

Sponsored by Mayo Clinic · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
42
Ages
50 Years and older
Sex
All
01

Study summary

We will evaluate the end to end remote monitoring system in a less controlled environment and concurrently develop the infrastructure to support the back end of the system

Read the detailed description

The overall objective of our research is to test, adapt, refine and validate the BodyGuardian technology and related end-to-end remote monitoring system to be used outside usual medical care environments to reduce hospital readmissions and facilitate independent living for heart failure patients. An important component of our overall strategy for continued development and refinement of the remote monitoring system is the incorporation of iterative behavioral evaluations to facilitate assessment and refinement in order to optimize adherence, utilization, and usability for patients as well as efficiency and functionality for providers.

02

Conditions studied

  • Congestive Heart Failure

Browse trials for

Keywords

  • Congestive Heart Failure
03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,219 are open to participants now.

This study's enrollment of 42 is below the median of 200 across 1,678 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Individuals >50 years with Congestive Heart Failure

Inclusion criteria

  • Outpatients
  • Stable New York Heart Association Class I-III HF (defined as no admissions for > 1 year)
  • Recruited from the Mayo Heart Failure Clinic, including 15 men and 15 women
  • Age > 50 years
  • Reside in Olmsted County

Exclusion criteria

Exclusion Criteria:

  • Hospital admission for HF within past year
  • Dementia
  • Overall life expectancy \< 2 months
  • Blindness
  • Pregnancy or women able to become pregnant
  • Skin allergy to adhesives
  • Inadequate cell phone coverage (international patients or international travel during study period)
  • Documented Ejection Fraction of >40%
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
42 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. adherence and utilization of end-to-end system in 30 subjects with stable New York Heart Association class I-III Heart Failure for 2 weeks

    To evaluate subject adherence, data transfer, clinical utilization and work-flow as well as perceptions and experiences of HF outpatients (n=30) and providers of the end-to-end remote monitoring system.

    Time frame: 12 months

Secondary outcomes

  1. effect of end-to-end system on life quality

    Evaluation of end-to-end remote monitoring system in a less controlled environment by evaluating ease of use and clinical management.

    Time frame: 12 months

Other outcomes

  1. Healthcare record integration

    Concurrently develop the infrastructure to support the back-end solution of the system including technician support, closed feedback loops to support care of the monitored subjects by an integrated team of health care providers, user-interfaces which display summarized data for the patient and other members of the healthcare team, and integration of summarized data into the Mayo electronic medical record.

    Time frame: 12 months

07

Study locations

3 sites
  • Mayo Clinic
    Jacksonville, Florida 32224, United States
  • Mayo Clinic Health System-Eau Claire Hospital, Inc.
    Eau Claire, Wisconsin 54702, United States
  • Mayo Clinic Health System-Franciscan Medical Center
    La Crosse, Wisconsin 54601, United States
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 21, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01975402
Lead sponsor
Mayo Clinic
Collaborators
Preventice, National Institute on Aging (NIA)
Responsible party
Lyle J. Olson, M.D. (PI, Mayo Clinic) — Principal investigator
First posted
Nov 3, 2013
Start date
Nov 2013
Primary completion
Mar 31, 2019
Completion
Mar 31, 2019
Last update
May 21, 2019

Study contacts

Lyle J Olson, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion